Bioluminescent Antibodies for Point-of-Care Diagnostics.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION(2017)

引用 57|浏览18
暂无评分
摘要
We introduce a general method to transform antibodies into ratiometric, bioluminescent sensor proteins for the no-wash quantification of analytes. Our approach is based on the genetic fusion of antibody fragments to NanoLuc luciferase and SNAP-tag, the latter being labeled with a synthetic fluorescent competitor of the antigen. Binding of the antigen, here synthetic drugs, by the sensor displaces the tethered fluorescent competitor from the antibody and disrupts bioluminescent resonance energy transfer (BRET) between the luciferase and fluorophore. The semisynthetic sensors display a tunable response range (submicromolar to submillimolar) and large dynamic range (Delta R-max>500%), and they permit the quantification of analytes through spotting of the samples onto paper followed by analysis with a digital camera.
更多
查看译文
关键词
antibodies,bioluminescence,point-of-care monitoring,sensors,therapeutic drug monitoring
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要